Use of ergoline derivatives for the treatment of glaucoma

Details Use of ergoline derivatives for the treatment of glaucoma Use of ergoline derivatives for the treatment of glaucoma

A - Human Necessities

61

K

A61K 31/48 (2006.01) A61K 9/00 (2006.01) A61K 9/107 (2006.01)

Patent

CA 2146006

The use of certain dopaminergic compounds for controlling elevations of intraocular pressure is disclosed. The compounds are ergoline derivatives. The most preferred compound is cabergoline. The compounds have been found to produce a significant reduction of intraocular pressure.

Utilisation de certains composés dopaminergiques dérivés de l'ergoline pour limiter l'accroissement de la pression intraoculaire, le composé de loin préféré étant la cabergoline. Ces composés se sont avérés capables de réduire la pression intraoculaire d'une matière significative.

Affiliated with

Also associated with

Rating

Use of ergoline derivatives for the treatment of glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ergoline derivatives for the treatment of glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ergoline derivatives for the treatment of glaucoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2029557